相关临床试验
84
23 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1871
进行中（未招募）
4
4.8%
已完成
28
33.3%
尚未招募
19
22.6%
招募中
27
32.1%
终止
4
4.8%
撤回
2
2.4%
暂无批准数据
- BioNTech has partnered with Peter MacCallum Cancer Centre to establish a clinical trial platform in Victoria, Australia, aimed at improving access to investigational therapies for hard-to-treat cancers. - The platform creates a network of key delivery partners including Austin Health, Alfred Health, and Monash Health to streamline clinical trials across Melbourne and regional Victoria. - BioNTech is also establishing a state-of-the-art facility in Victoria in partnership with mRNA Vic to support research, development, and clinical-scale manufacturing of mRNA-based medicines. - The initiative leverages Victoria's thriving biomedical ecosystem and world-class cancer survival rates to potentially unlock breakthrough cancer treatments.
- A groundbreaking clinical trial at Alfred Health is offering new treatment options for severe eczema sufferers through an innovative teletrial model, allowing patients to receive care closer to home. - The international study, also running in the US and Canada, is testing a novel treatment for moderate to severe eczema with Latrobe Regional Health becoming one of the first non-metropolitan hospitals worldwide to participate. - After a year of treatment, the trial's first teletrial participant experienced significant improvement with reduced flare-ups and decreased reliance on steroid medications, demonstrating the potential impact of this accessible care model.
